Ali Rihani

1.1k citations
22 papers · 978 · h-index 14

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
  • Neurology top 10%
    • Neuroblastoma Research and Treatments

Papers in

    • Neuroblastoma Research and Treatments 6
    • Cancer-related Molecular Pathways 5

Ali Rihani

21 papers receiving 969 citations

Peers

Ali Rihani
Comparison fields: 5 of 86
  • Cancer Research 211
  • Neurology 179
  • Oncology 142
  • Molecular Biology 299
  • Physiology 14
Replace Irina Lambertz with:
Irina Lambertz Belgium
Sara De Brouwer Belgium
Gert Van Peer Belgium
Tanel Punga Sweden
Benjamin H. Peng United States
Alexander M. Gout United States
Mike Hupe Germany
Xiuli Wang China
Ventzislava A. Hristova United States
Qin Zou China
Ali Rihani relative to Irina Lambertz Belgium Irina Lambertz's profile →
Citations per field
00.5×1.6×
Irina Lambertz · 1×
Citations per year

Countries citing papers authored by Ali Rihani

Since Specialization
Citations

This map shows the geographic impact of Ali Rihani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Rihani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Rihani more than expected).

Fields of papers citing papers by Ali Rihani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Rihani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Rihani. The network helps show where Ali Rihani may publish in the future.

Co-authors

The 25 scholars most cited alongside Ali Rihani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ali Rihani Line = papers co-authored together Ali Rihani links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2013251
2 2010125
3 2009104
4 201479
5 201165
6 200957
7 201343
8 201441
9 201540
10 201533
11 201130
12 201930
13 201420
14 202015
15 201312
16 201811
17 202011
18 20215
19 20144
20
Selective inhibition of the p53–MDM2 interaction by nutlin drugs: a new therapeutic perspective for neuroblastoma
20131

About Ali Rihani

Ali Rihani is a scholar working on Neurology, Oncology, Cancer Research, Molecular Biology and Genetics, having authored 22 papers that have together received 978 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (6 papers), Cancer-related Molecular Pathways (5 papers), Molecular Biology Techniques and Applications (5 papers), MicroRNA in disease regulation (2 papers), Genomic variations and chromosomal abnormalities (1 paper), Estrogen and related hormone effects (1 paper), Protein Degradation and Inhibitors (1 paper) and Influenza Virus Research Studies (1 paper). The work is most often cited by research in Cancer Research (211 citations), Neurology (179 citations), Oncology (142 citations), Molecular Biology (299 citations) and Physiology (14 citations). Ali Rihani has collaborated with scholars based in Belgium, Sweden and Germany. Frequent co-authors include Jo Vandesompele, Frank Speleman, Tom Van Maerken, Anne De Paepe, Alan Van Goethem, Steve Lefever, Jean‐Christophe Marine, Nurten Yigit, Gert Van Peer and Pieter Mestdagh. Their work appears in journals such as Scientific Reports, PLoS ONE, Molecular Cancer Therapeutics, Nature Methods and Pediatric Blood & Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact